Tam C - Search Results

1

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy.

Hughes CF, Khot A, McCormack C, Lade S, Westerman DA, Twigger R, Buelens O, Newland K, Tam C, Dickinson M, Ryan G, Ritchie D, Wood C, Prince HM. Hughes CF, et al. Among authors: tam c. Blood. 2015 Jan 1;125(1):71-81. doi: 10.1182/blood-2014-07-588236. Epub 2014 Oct 21. Blood. 2015. PMID: 25336628 Free article.

2

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 May 15;100(10):2181-9. doi: 10.1002/cncr.20234. Cancer. 2004. PMID: 15139062 Free article. Review.

3

Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.

Tam CS, Prince HM, Westerman D, Seymour JF, Juneja S. Tam CS, et al. Leuk Lymphoma. 2004 Apr;45(4):705-10. doi: 10.1080/10428190310001615657. Leuk Lymphoma. 2004. PMID: 15160943 Review.

4

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.

Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Tam CS, et al. Am J Hematol. 2004 Sep;77(1):72-6. doi: 10.1002/ajh.20147. Am J Hematol. 2004. PMID: 15307110 Free article.

5

A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Grigg AP, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 Nov 1;101(9):2042-9. doi: 10.1002/cncr.20615. Cancer. 2004. PMID: 15372472 Free article.

6

Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia.

Chionh F, Herbert KE, Seymour JF, Prince HM, Wolf M, Zimet A, Tam C, Kennedy GA. Chionh F, et al. Among authors: tam c. Leuk Lymphoma. 2005 Apr;46(4):603-5. doi: 10.1080/10428190400025138. Leuk Lymphoma. 2005. PMID: 16019490

7

Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.

Tam CS, Wolf MM, Westerman D, Januszewicz EH, Prince HM, Seymour JF. Tam CS, et al. Clin Lymphoma Myeloma. 2005 Sep;6(2):136-9. doi: 10.3816/CLM.2005.n.040. Clin Lymphoma Myeloma. 2005. PMID: 16231852

8

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.

Tam CS, Wolf M, Prince HM, Januszewicz EH, Westerman D, Lin KI, Carney D, Seymour JF. Tam CS, et al. Cancer. 2006 Jun 1;106(11):2412-20. doi: 10.1002/cncr.21882. Cancer. 2006. PMID: 16649223 Free article.

9

The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.

Polizzotto MN, Tam CS, Milner A, Januszewicz EH, Prince HM, Westerman D, Wolf MM, Seymour JF. Polizzotto MN, et al. Cancer. 2006 Aug 15;107(4):773-80. doi: 10.1002/cncr.22022. Cancer. 2006. PMID: 16847886 Free article.

10

Treatment-related myelodysplasia following fludarabine combination chemotherapy.

Tam CS, Seymour JF, Prince HM, Kenealy M, Wolf M, Januszewicz EH, Westerman D. Tam CS, et al. Haematologica. 2006 Nov;91(11):1546-50. Haematologica. 2006. PMID: 17082012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,441 results

Search Page

Filters